The Complexity of Translating Anti-angiogenesis Therapy from Basic Science to the Clinic

Area of Science:

• Oncology
• Vascular Biology

Background:

• Tumor angiogenesis is essential for cancer growth and progression.
• Blocking tumor angiogenesis is a validated anti-cancer strategy.

Purpose of the Study:

• To summarize key lessons learned from clinical applications of anti-angiogenesis therapies.
• To provide insights into improving future anti-angiogenesis treatments.

Main Methods:

• Review of clinical experience and research in tumor angiogenesis.
• Analysis of the impact of anti-angiogenesis agents in cancer therapy.

Main Results:

• Anti-angiogenesis agents are now standard-of-care for numerous cancers.
• Clinical application has provided significant insights into the efficacy and limitations of this approach.

Conclusions:

• Decades of research have translated the concept of blocking tumor angiogenesis into clinical benefit.
• Leveraging accumulated clinical experience is crucial for advancing anti-angiogenesis therapy.